| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 02/11/2004 | CN1474803A Novel amide derivatives and medicinal use thereof |
| 02/11/2004 | CN1474702A Oral pharmaceutical composition containing a block copolymer |
| 02/11/2004 | CN1474681A Novel coupler for use in oxidative hair dyeing |
| 02/11/2004 | CN1137883C Aromatic carboxylic acid ester, its production and use of same as medicaments |
| 02/11/2004 | CN1137878C Aryloxyaniline derivatives |
| 02/10/2004 | US6689909 Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 02/10/2004 | US6689896 Thyromimetic organic compounds |
| 02/10/2004 | US6689888 Processes and intermediates useful in preparing β3-adrenergic receptor agonists |
| 02/10/2004 | US6689801 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
| 02/10/2004 | US6689793 Piperidinylethyl-, phenoxyethyl-, and β-fluorophenethyl-substituted thiourea compounds with potent anti-HIV activity |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/10/2004 | US6689780 Heteroroaromatic amides as inhibitor of factor Xa |
| 02/10/2004 | US6689773 Uracil substituted phenyl sulfamoyl carboxamides |
| 02/10/2004 | US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase |
| 02/10/2004 | US6689754 Heterocyclic glycyl β-alanine derivatives |
| 02/10/2004 | US6689291 Liquid-crystalline medium |
| 02/09/2004 | CA2436658A1 Polynuclear metal complexes as phosphorescence emitters in electroluminescent layer arrangements |
| 02/05/2004 | WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 02/05/2004 | WO2004011417A1 N-bisaryl- and n-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides |
| 02/05/2004 | WO2004011410A1 Chemical compounds |
| 02/05/2004 | WO2004010945A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 02/05/2004 | WO2003082823A3 Pro-dyes containing compositions for dyeing keratinous fibers |
| 02/05/2004 | WO2003075857A3 Amino-methyl substituted tetracycline compounds |
| 02/05/2004 | WO2003074475A3 Substituted aryl ketones |
| 02/05/2004 | WO2002087555A3 Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer |
| 02/05/2004 | US20040024224 Synthesis of 2-alkyl amino acids |
| 02/05/2004 | US20040024219 Reacting acid chloride with phenylalanine in solvent comprising potassium hydroxide; for production drugs |
| 02/05/2004 | US20040024215 Such as 4'-trifluoromethyl-biphenyl-2-carboxylic acid(4-(4-(alpha-methyl-benzyl)-piperazin-1-yl)-phenyl)-amide; apoprotein B-100 (apoB-100) and microsomal triglyceride transfer protein (MTP) |
| 02/05/2004 | US20040024208 Cyclic protein tyrosine kinase inhibitors |
| 02/05/2004 | US20040024059 Novel pleuromutilin derivatives |
| 02/05/2004 | US20040024045 Glucagon antagonists/inverse agonists |
| 02/05/2004 | US20040023999 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/05/2004 | US20040023986 Treating epilepsy, neuropathic pain, and tissue damage form ischemic events; antihypoxic agents |
| 02/05/2004 | US20040023973 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof. |
| 02/05/2004 | US20040023942 Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases |
| 02/05/2004 | US20040023933 Use for the treatment of diseases having an inflammatory basis of compounds or salts thereof, having the following general formula (I): A-Xt-L-(W)p-NO2 wherein A contains the radical of a drug, Xt and W arc bivalent radicals, L, is a |
| 02/05/2004 | US20040023932 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the |
| 02/05/2004 | US20040023806 Agrochemicals in agriculture for controlling acarids and insects and for preventing the infestation of crop plants by phytopathogenic fungi. |
| 02/05/2004 | US20040022856 Carriers for drug delivery |
| 02/05/2004 | US20040022831 For therapy of mycosis of the nail |
| 02/05/2004 | US20040021928 Electrolytes for electrooptic devices comprising ionic liquids |
| 02/05/2004 | US20040020404 Printing an image on a substrate comprising applying thereto a formulation comprising a liquid medium and a compound containing azo groups and metallized 1,8-dihydroxynaphthyl group |
| 02/05/2004 | CA2494668A1 Chemical compounds |
| 02/05/2004 | CA2493975A1 N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides |
| 02/05/2004 | CA2493156A1 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 02/04/2004 | EP1386912A1 Cyclic amidine derivative |
| 02/04/2004 | EP1386908A1 Amine derivative with potassium channel regulatory function, its preparation and use |
| 02/04/2004 | EP1385912A1 Pyridone dyes, a process for their preparation and their use in the production of coloured plastics or polymeric colour particles |
| 02/04/2004 | EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 02/04/2004 | EP1385824A2 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| 02/04/2004 | EP1385820A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 02/04/2004 | EP1385818A2 Biurethane derivatives |
| 02/04/2004 | EP1385577A2 Use of nk-1 receptor antagonists against benign prostatic hyperplasia |
| 02/04/2004 | EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
| 02/04/2004 | EP1236717B1 Oxime o-ether compounds and fungicides for agricultural and horticultural use |
| 02/04/2004 | EP1115697B1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 02/04/2004 | EP0813525B9 Benzamidine derivatives their preparation and their use as anti-coagulants |
| 02/04/2004 | CN1137090C New processes for preparing pesticidal intermediates |
| 02/03/2004 | US6686503 Splititng from solid support; methylation |
| 02/03/2004 | US6686395 2′-substituted 1,1′-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 02/03/2004 | US6686378 Derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 02/03/2004 | US6686368 Inhibitors of factor Xa |
| 02/03/2004 | US6686364 4-hydroxy-3-((3,5-difluoro-6-(3 -dimethylaminocarbonylphenoxy)-4-(2-methoxy-4-carboxyphenoxy) pyridin-2-yl)oxy)benzamidine, for example; factor xa inhibitors |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686350 Cell adhesion inhibitors |
| 02/03/2004 | US6686134 Photographic processing composition containing heterocycle combination and method of forming image |
| 01/29/2004 | WO2004009561A1 3-heterocyclyl substituted benzoic acid derivatives |
| 01/29/2004 | WO2004009554A1 Process for the preparation of modification i of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide |
| 01/29/2004 | WO2004009553A1 Process for producing 5-(2'-pyridyl)-2-pyridone derivative |
| 01/29/2004 | WO2004009552A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | WO2004009551A1 Process for producing 2-substituted pyridine derivative |
| 01/29/2004 | WO2004009533A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/29/2004 | WO2004009527A1 Materials and methods for treating hypercholesterolemia |
| 01/29/2004 | WO2004009034A2 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | WO2003078396A8 Preparation of n1-(2’-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
| 01/29/2004 | WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/29/2004 | WO2003059864A3 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 01/29/2004 | WO2003053971A8 Pyridoquinoxaline antivirals |
| 01/29/2004 | WO2002038106A3 Calcilytic compounds |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019190 Thrombopoietin mimetics |
| 01/29/2004 | US20040019156 Comprises metal bromide oxidation catalysts, in liquid phase using acetic acid as solvent; waste treatment |
| 01/29/2004 | US20040019106 Cyano and carboxy derivatives of substituted styrenes; inhibitors of tumor necrosis factor alpha, nuclear factor kappa B, and phosphodiesterase |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040019094 N-imine guanidine compounds; treatment of obesity, anorexia, inflammation and mental disorders |
| 01/29/2004 | US20040019087 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | US20040019086 Aminediols for the treatment of Alzheimer's disease |
| 01/29/2004 | US20040019072 Dimer-selective RXR modulators and methods for their use |
| 01/29/2004 | US20040019052 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 01/29/2004 | US20040019047 E.g., 5-bromo-2-(4-chloroanilino)-4-(2,4,6-trimethylphenoxy) pyridine-N-oxide; administering along with an HIV reverse transcriptase inhibitors (polymerase), HIV protease inhibitors, fusion inhibitors or CCR-5; kits |
| 01/29/2004 | US20040019044 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 01/29/2004 | US20040019043 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | US20040019039 Substituted piperazines and diazepanes |
| 01/29/2004 | US20040019038 Compounds useful as anti-inflammatory agents |
| 01/29/2004 | US20040019037 E.g.,((5-(2,4-Diaminopyrimidin-6-yl)pentanoyl)-(N-methyl)amino )-3-(6-meth-oxypyridin-3-yl)-propanoic acid, inhibition of bone resorption, restenosis, angiogenesis inhibitors, antiarthritic, -tumor, -carcinogenic agents; antidiabetic |
| 01/29/2004 | US20040016063 1,3-Dihydroxybenzene derivatives and colorants containing said compounds |
| 01/29/2004 | DE10232525A1 Neue Anthracen-Derivate und deren Verwendung als Arzneimittel Novel anthracene derivatives and their use as medicaments |
| 01/29/2004 | CA2493457A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/29/2004 | CA2493127A1 Thiomolybdate analogues and uses thereof |